Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share - Anti-dilutive Securities (Details)

v3.24.2.u1
Net Loss per Common Share - Anti-dilutive Securities (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Effect of dilutive securities:        
Potentially dilutive securities (in shares) 31,147,090 28,250,387 31,147,090 28,250,387
Warrants to purchase shares of common stock        
Effect of dilutive securities:        
Potentially dilutive securities (in shares) 14,166,644 14,166,644 14,166,644 14,166,644
Options to purchase shares of common stock        
Effect of dilutive securities:        
Potentially dilutive securities (in shares) 6,585,611 7,303,079 6,585,611 7,303,079
Restricted shares of common stock        
Effect of dilutive securities:        
Potentially dilutive securities (in shares) 10,394,835 6,780,664 10,394,835 6,780,664